Showing results (131-140 of 242) with videos related to
Sort By:
Pageof 25
Ultrastructural Pathology|September 1, 1988
An immunoelectron microscopic study of glucocerebrosidase in type 1 Gaucher's disease spleenR Willemsen, J M van Dongen, J M Aerts, et al.Pediatric Research|February 11, 2012
Height, BMI, and pituitary volume in individuals with and without isolated cleft lip and/or palateEllen van der Plas, Chelsea J Caspell, Andrea M Aerts, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 30, 2020
Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry diseaseDaniel G Bichet, Johannes M Aerts, Christiane Auray-Blais, et al.Methods of Information in Medicine|June 29, 2010
Assessment of pain expression in infant cry signals using empirical mode decompositionB Mijović, M Silva, B R H Van den Bergh, et al.Journal of Pharmaceutical and Biomedical Analysis|January 1, 1989
Determination of sulfadimethoxine, sulfamethoxazole, trimethoprim and their main metabolites in porcine plasma by column switching HPLCM J Mengelers, M B Oorsprong, H A Kuiper, et al.Biochimica Et Biophysica Acta|December 16, 1996
Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher diseaseH Michelakakis, C Spanou, A Kondyli, et al.The Journal of Clinical Endocrinology and Metabolism|February 1, 2007
Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjectsM J Serlie, A J Meijer, J E Groener, et al.Experimental Cell Research|August 1, 1988
Characterization of glucocerebrosidase in peripheral blood cells and cultured blastoid cellsJ M Aerts, J Heikoop, S van Weely, et al.Tissue & Cell|March 16, 2015
Relative distribution of gastrin-, CCK-8-, NPY- and CGRP-immunoreactive cells in the digestive tract of dorado (Salminus brasiliensis)R T Pereira, L S Costa, I R C Oliveira, et al.The American Journal of Medicine|October 8, 1997
Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher diseaseC E Hollak, E P Corssmit, J M Aerts, et al.Pageof 25